CD8A and neoplasm: Visus et al. reported that adoptive transferred ALDH1A1-specific CD8+T cells could target the ALDHbright cells, inhibit subcutaneous tumor growth, prevent metastasis and prolong the survival of the tumor-bearing mice [24].